(5-BROMO-3-METHYLPYRIDIN-2-YL)METHANAMINE HCL, 95.0%, 100mg

Ethyl 2-(benzo[c][1,2,5]thiadiazol-5-yl)acetate, 97.0%, 5g

(3R)-(-)-1-Benzyl-3-aminopyrrolidine>98.0%(GC)(T)10g

Ethyl 2-oxo-4-phenylbutanoate, 95.0%, 5g

6-(piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 500mg

(8-Fluoroquinolin-6-yl)boronic acid, 95.0%, 100mg

1-(TRIISOPROPYLSILYL)-1H-INDOLE-6-SULFONYLCHLORIDE, 95.0%, 5g

4-Chloro-6-(4-methoxy-phenyl)-thieno[3,2-d]-pyrimidine, 1g

2-[4-(1-Methyl-1-phenylethyl)phenoxy]-acetohydrazide, 95.0%, 5g

Methyl 2-chloro-3-iodo-4-methylbenzoate, 95%, 500mg

1-[(oxolan-3-yl)methyl]-1H-1,2,3-triazole-4-carboxylic acid, 95.0%, 1g

Tungsten boride powder 99+% 50 g

m-toluic acid, 98%, for synthesis, 250 g, plastic packaging.